“…Between the 1960s and the 1980s, intensive care of preterm newborns was limited to intravenous fluid administration, assisted ventilation (by endotracheal intubation), and oxygen monitoring (Hack & Costello, 2008). The 1990s saw widespread adoption of surfactant to treat or prevent severe respiratory distress syndrome in preterm neonates, and prenatal administration of synthetic glucocorticoids, to maximally develop lung function in fetuses at risk (e.g., Ferrara et al, 1991;Göpel et al, 2015;Hoekstra, Ferrara, Couser, Payne, & Connett, 2004;Pelkonen, Hakulinen, Turpeinen, & Hallman, 1998;Verder et al, 1994). Concomitantly, survival of preterm infants increased during the 1990s in the United States (Fanaroff et al, 1995;Hoekstra et al, 2004), Britain (Riley, Roth, Sellwood, & Wyatt, 2008), and Australia, (Doyle, 2006;Doyle, & the Victorian Infant Collaborative Study Group, 2004).…”